Related references
Note: Only part of the references are listed.Apoptotic neuronal death in Parkinson's disease: Involvement of nitric oxide
Sarika Singh et al.
BRAIN RESEARCH REVIEWS (2007)
Nitrite and malondialdehyde content in cerebrospinal fluid of patients with Parkinson's disease
R. Shukla et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2006)
Nitric oxide synthase regulation and diversity: Implications in Parkinson's disease
Ramkumar Kavya et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2006)
Expanding insights of mitochondrial dysfunction in Parkinson's disease
PM Abou-Sleiman et al.
NATURE REVIEWS NEUROSCIENCE (2006)
Synergistic inhibition of respiration in brain mitochondria by nitric oxide and dihydroxyphenylacetic acid (DOPAC) Implications for Parkinson's disease
C Nunes et al.
NEUROCHEMISTRY INTERNATIONAL (2005)
The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease
E Carro et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Role of insulin-like growth factor I signaling in neurodegenerative diseases
JL Trejo et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2004)
Neurodegeneration or neuroprotection: The pivotal role of astrocytes
SJR Heales et al.
NEUROCHEMICAL RESEARCH (2004)
Movement disorder society task force report on the Hoehn and Yahr staging scale: Status and recommendations
CG Goetz et al.
MOVEMENT DISORDERS (2004)
N-terminal tripeptide of IGF-I improves functional deficits after 6-OHDA lesion in rats
R Krishnamurthi et al.
NEUROREPORT (2004)
Cerebrospinal fluid insulin-like growth factor-1, insulin growth factor binding protein-2 or nitric oxide are not increased in MS or ALS
T Pirttilä et al.
ACTA NEUROLOGICA SCANDINAVICA (2004)
Nitric oxide:: NO apoptosis or turning it ON?
B Brüne
CELL DEATH AND DIFFERENTIATION (2003)
Protective effect of insulin-like-growth-factor-1 against dopamine-induced neurotoxicity in human and rodent neuronal cultures: possible implications for Parkinson's disease
D Offen et al.
NEUROSCIENCE LETTERS (2001)
Neurodegeneration is associated to changes in serum insulin-like growth factors
S Busiguina et al.
NEUROBIOLOGY OF DISEASE (2000)
N-terminal tripeptide of IGF-1 (GPE) prevents the loss of TH positive neurons after 6-OHDA induced nigral lesion in rats
J Guan et al.
BRAIN RESEARCH (2000)